Homogeneous Emphysema Patients Could Benefit from Zephyr Endobronchial Valve, Study Shows
Emphysema, News
Pulmonx recently announced positive results from the IMPACT (NCT02025205) study assessing the company’s proprietary Zephyr endobronchial valve (EBV), showing that patients with homogeneous emphysema benefit from the treatment. The Zephyr EBV is ... Read more